Liver fibrosis is characterized by scar formation as a response to injury. Although many drugs have demonstrated antifibrotic efficacy in vitro and in animal models, effectively translating these into effective clinical therapies remains a challenge. Nanotechnology offers potential therapeutic approaches for treating liver fibrosis. This study aimed to assess and compare the antifibrotic effects of losartan and losartan nanoparticles (LP-NPs) on CCl4-induced liver fibrosis in rats.Thirty-two adult male Sprague-Dawley rats were divided into four groups: a control group, a CCl4-induced fibrosis group, a losartan-treated group, and an LP-NPs-treated group. Liver fibrosis was induced by CCl4 injections over six weeks. Losartan or LP-NPs were orally administered for four weeks. At the conclusion of the study, rats were euthanized, and blood samples were collected for liver enzyme assessment. Liver specimens were subjected to histopathological examination (H&E, Sirius red staining), immunohistochemistry (α-SMA and TIMP1), and quantitative real-time PCR (qRT-PCR) for gene expression analysis of α-SMA and TIMP1. Morphometrical studies quantified collagen areas in Sirius red-stained sections and optical density of α-SMA and TIMP1 in immunohistochemically stained sections.The results showed that CCl4 induced significantly elevated liver enzymes, severe distortion of hepatic architecture, marked steatosis and fibrosis. Additionally, there was an increase in collagen content, accompanied by strong positive immunostaining and upregulated gene expression of α-SMA and TIMP1. Both losartan and LP-NPs treatments significantly improved these parameters compared to the CCl4-only group. Notably, LP-NPs demonstrated significantly greater improvements in liver enzyme levels, collagen percentage area, and the gene expression of α-SMA and TIMP1 compared to the standard losartan group. However, no significant difference was observed between the two treatments in α-SMA optical density.In conclusion, this investigation demonstrates that nanoformulation significantly enhanced losartan’s antifibrotic efficacy. LP-NPs improved liver function and histological architecture, reduced collagen content after CCl4 administration, and demonstrated greater therapeutic efficacy than conventional losartan.
International Journal of Clinical and Medical Research · مجلد 3 (1) · 34-39
Arthritis represents a heterogeneous group of inflammatory and degenerative joint disorders characterized by persistent inflammation, oxidative stress, cartilage degradation, synovial dysfunction and progressive impairment of joint integrity. Rheumatoid Arthritis (RA) and Osteoarthritis (OA), although distinct in etiology, share several pathological mechanisms involving excessive production of Reactive Oxygen Species (ROS), mitochondrial dysfunction, inflammatory cytokine activation and dysregulation of redox-sensitive signaling pathways [1-4]. The nuclear factor erythroid 2-related factor 2 (Nrf2)-Kelch-like ECH-associated protein 1 (Keap1) pathway is a major endogenous defense mechanism responsible for maintaining cellular redox homeostasis. Under basal conditions, Keap1 promotes Nrf2 degradation; however, oxidative or electrophilic stress disrupts this interaction, allowing Nrf2 to accumulate and translocate into the nucleus, where it activates antioxidant response element (ARE)-dependent genes, including heme oxygenase-1 (HO-1), NAD(P)H quinone dehydrogenase 1 (NQO1) and glutathione-related enzymes [5,6]. Increasing evidence indicates that impaired or insufficient Nrf2 activity contributes to persistent oxidative stress and inflammation in arthritic joints [1,7]. Nrf2 also interacts with major inflammatory pathways, particularly nuclear factor-kappa B (NF-κB), mitogen-activated protein kinase (MAPK) and NLRP3 inflammasome signaling [8]. Nanotechnology offers an opportunity to improve the delivery, stability, bioavailability and tissue targeting of therapeutic agents capable of modulating redox and inflammatory pathways. Among different nanomaterials, silver nanoparticles (AgNPs) have attracted considerable interest because of their antimicrobial, anti-inflammatory, antioxidant and immunomodulatory properties [9-11]. Experimental studies have demonstrated that AgNPs can reduce inflammatory cytokines, regulate NF-κB and MAPK signaling, influence macrophage polarization and alleviate inflammatory tissue injury [9,10]. In experimental RA, targeted folic-acid-modified AgNPs have demonstrated the ability to interact with inflammatory macrophages, promote macrophage apoptosis and repolarization and reduce disease severity [12]. Nevertheless, the relationship between AgNP exposure, oxidative signaling and Nrf2-Keap1 activation is complex and excessive nanoparticle-induced oxidative stress may also produce adverse biological effects. This review examines the role of the Nrf2-Keap1 pathway in arthritis, evaluates nanoparticle-based strategies for modulating redox and inflammatory mechanisms and critically discusses the therapeutic potential and safety considerations of AgNPs. Particular emphasis is placed on the potential intersection between AgNP-mediated redox regulation, Nrf2-Keap1 signaling, NF-κB inhibition, macrophage polarization and joint protection.
Cancer is a leading global cause of death, with complex pathogenesis and treatment challenges like poor selectivity, toxicity, and drug resistance. Nanotechnology offers transformative solutions, with plant-derived exosomes (EXOs) emerging as promising green nanomaterials for personalized cancer therapy because of their biocompatibility and minimal antigenicity, and eco-friendly production. This review discusses the potential of plant EXOs in cancer treatment, covering isolation methods, advantages over mammalian EXOs (e.g., stability, cost-effectiveness, and evasion of drug resistance mechanisms), and preclinical applications. For instance, ginger EXOs suppress colorectal cancer via cytokine modulation, grapefruit EXOs target brain tumors, and lemon EXOs induce apoptosis in triple-negative breast cancer. Plant EXOs also enhance drug delivery when loaded with chemotherapeutics, nucleic acids, or immunomodulators, improving precision and reducing off-target effects. Despite their promise, challenges remain in scalability, purity, long-term safety for non-oral routes, and clinical translation. Future research must optimize isolation techniques, clarify molecular mechanisms, and validate pharmacokinetics to advance clinical adoption. This review offers a complete examination of plant EXOs, including biogenesis, characterization, engineering strategies, anti-cancer mechanisms (e.g., apoptosis induction, immune modulation), and therapeutic applications. It also addresses hurdles like standardization and regulatory gaps while advocating interdisciplinary collaboration to bridge lab-to-clinic gaps. By harnessing plant EXOs' potential, this work highlights a path toward sustainable, targeted cancer therapies, urging further innovation to overcome existing barriers and realize their full clinical impact.
Frontiers in Pharmacology · مجلد 16 · 1605717-1605717
Introduction Nanotechnology is an innovative approach that involves the development, production, and application of materials via altering their shape and size on the nanometer scale, which ranges from 1 to 100 nm. Zinc Oxide Nanoparticles (ZnONPs) are metal-oxide nanomaterials with distinct physical and chemical properties that make them valuable and adaptable inorganic compounds. Methods The C. revoluta extract was subjected to comprehensive phytochemical analysis, and showed presence of triterpenoids, alkaloids, saponins, steroids, resins, diterpenes, and coumarins. The ZnONPs synthesized using C. revoluta extract were optimized by synthesizing zinc nanoparticles at different temperatures and pH. The synthesis of ZnONPs was determined by the UV–Vis spectrophotometry, with the absorbed peak being observed at 364 nm. The characterization of ZnONPs was performed with XRD, FTIR, SEM, TEM, and EDX analysis. Results The surface morphology of the ZnONPs was analyzed using SEM, which revealed their spherical nature and particle size was determined to be 30 nm. Significant peaks were observed in the XRD pattern, confirming their sphere-like structure. FTIR spectra were recorded to determine the groups of biomolecules involved in synthesis. ZnONPs’ antibacterial efficacy against gram + ve and gram -ve bacteria, were positive. The ZnONPs demonstrated significant cytotoxic activity against TNBC MDAMB-231 cell line with an IC50 of 58.39 μg/mL. The percentage DPPH radical scavenging activity was 72.36% at 100 μg/mL concentration. Furthermore, ZnONPs showed significant (p < 0.001) wound healing characteristics in the excision wound model in rats with 99.29% wound contraction on treatment Day 16. Discussion The ZnONPs showed increased cell migration potential in the in vitro scratch assay, highlighting their potential for wound care and tissue regeneration applications. In future, more in-depth research and clinical evaluation are warranted to fully explore the therapeutic potential of these environmentally friendly ZnONPs.
Critical Reviews in Food Science and Nutrition · مجلد 66 (17) · 3175-3201
Heavy metal contamination in the environment has risen due to industrialization, posing serious health risks through food chain accumulation. Fruit juices, rich in essential nutrients, may also contain harmful metal residues, particularly endangering children due to their higher consumption. Ensuring food safety requires thorough investigation and effective removal of heavy metals to protect public health and promote informed nutrition choices. To make food safe for human consumption, researchers have been working tirelessly to remove impurities from it. This paper reviews the current state of research on the various sources of heavy metal contamination in juices, its health implications and various methods employed to remove heavy metals (physical, chemical, biological and nonthermal). Besides, advanced emerging technologies like nanotechnology, membrane filtration, electrochemical methods, cold plasma, and ozone for the removal of heavy metals have also been discussed. Ozone removes heavy metals from fruit juices through oxidation, where it reacts with metal ions to form insoluble oxides or hydroxides that can be easily filtered out. Cold plasma generates reactive species that interact with heavy metal ions in fruit juices, inducing redox reactions that convert them into less soluble or volatile forms for easy removal.
heavy metal removalfruit juiceheavy metal contaminationfood safety
Nanotechnology-enhanced materials and smart implants are emerging technologies that have shown promise in addressing various challenges in general surgery, including infection management, oncologic staging, and complication monitoring. In this systematic review, we aimed to examine the safety and efficacy of these technologies compared with conventional methods in patients undergoing general surgical procedures. A comprehensive search was conducted in MEDLINE (via PubMed), Embase, Scopus, Web of Science, the Cochrane Central Register of Controlled Trials, ClinicalTrials.gov, WHO ICTRP, IEEE Xplore/Inspec, and Google Scholar according to the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines, using standardized keywords related to nanotechnology, surgery, and clinical outcomes. The included studies were categorized according to intervention class and procedural type. Risk of bias was assessed using RoB 2 for randomized trials and ROBINS-I for nonrandomized studies, while outcome certainty was evaluated using GRADE. Nine eligible studies were included, comprising a total of 2,250 participants (infection prevention: 974; mapping/staging: 1,244; sensing: 32 drain-fluid samples). Due to heterogeneity among the studies, a meta-analysis could not be performed, and the results were therefore synthesized narratively. Silver-based topical creams and dressings demonstrated early bacterial clearance and improved wound healing. Carbon nanoparticle (CNP) suspensions enhanced lymph node detection sensitivity and preserved parathyroid hormone in thyroid cancer and nearly doubled sensitivity to micrometastatic lymph nodes in gastric cancer. Silver-ion-impregnated tracers in breast cancer showed comparable sensitivity for sentinel lymph node detection. Silver-ion-impregnated meshes showed no significant difference compared with conventional meshes. Overall, adverse effects were minimal or absent. In conclusion, nanotechnology-enhanced materials and smart implants show substantial potential to improve infection prevention, oncologic staging, and perioperative monitoring in general surgery, with minimal adverse effects. Silver-based topical antimicrobials, CNP suspensions, superparamagnetic iron oxide tracers, and innovative biosensor technologies were either comparable or superior to conventional alternatives. However, a clear knowledge gap regarding long-term outcomes and the heterogeneity of comparators highlights the need for larger, rigorously designed studies to guide clinical adoption.
smart implantsgeneral surgerysurgical site infection preventionlymphatic mapping
Abstract Green nanotechnology is an emerging approach in agriculture that plays a vital role in crop production with environmental integrity and sustainability. Iron plays a significant role in plant growth and metabolic activities like DNA synthesis, respiration, and photosynthesis. Therefore, the present investigation was conducted to examine the effect of seed priming with green‐synthesized iron nanoparticles (FeNPs) on the antioxidant responses of chickpea. FeNPs were synthesized using Bauhinia purpurea leaf extract and characterized by scanning electron microscopy, X‐ray diffraction, UV–visible spectroscopy, and particle size analyzer. The analysis showed a maximal absorption peak at 250 nm and a mean diameter of 95.9 nm. The optimization of seed priming with FeNPs comprised an 8 h duration and a concentration range of 50–250 ppm. The FeNPs were used in a greenhouse experiment to evaluate their effect on antioxidant enzymes in chickpea leaves at 50% flowering stage. The concentration of 150 ppm showed the highest ascorbate oxidase, glutathione reductase, catalase, superoxide dismutase, and peroxidase activity with 26.57%, 32.61%, 36.91%, 37.57%, and 58.61% increase, respectively, in comparison to the control. This investigation shows that FeNPs synthesized using B. purpurea elevate antioxidant enzyme activity in chickpea in a dose‐dependent manner. The overall study revealed that seed priming with FeNPs can be used as a potential strategy to enhance the first line of defense system and antioxidant potential. Antioxidant enzymes like catalase, superoxide dismutase, and peroxidase neutralize free radicals, reduce oxidative stress, and prevent cellular damage in plant tissues. Thus, augmented levels of these enzymes may enhance physiological function, improve growth, and support better stress tolerance. Although increased antioxidant enzyme activity benefits plant health, further investigations are needed to check downstream effects on human nutrition and health.
Beilstein Journal of Nanotechnology · مجلد 15 · 1473-1497
Phytochemicals, naturally occurring compounds in plants, possess a wide range of therapeutic properties, including antioxidant, anti-inflammatory, anticancer, and antimicrobial activities. However, their clinical application is often hindered by poor water solubility, low bioavailability, rapid metabolism, and instability under physiological conditions. Polymer lipid hybrid nanoparticles (PLHNPs) have emerged as a novel delivery system that combines the advantages of both polymeric and lipid-based nanoparticles to overcome these challenges. This review explores the potential of PLHNPs to enhance the delivery and efficacy of phytochemicals for biomedical applications. We discuss the obstacles in the conventional delivery of phytochemicals, the fundamental architecture of PLHNPs, and the types of PLHNPs, highlighting their ability to improve encapsulation efficiency, stability, and controlled release of the encapsulated phytochemicals. In addition, the surface modification strategies to improve overall therapeutic efficacy by site-specific delivery of encapsulated phytochemicals are also discussed. Furthermore, we extensively discuss the preclinical studies on phytochemical encapsulated PLHNPs for the management of different diseases. Additionally, we explore the challenges ahead and prospects of PLHNPs regarding their widespread use in clinical settings. Overall, PLHNPs hold strong potential for the effective delivery of phytochemicals for biomedical applications. As per the findings from pre-clinical studies, this may offer a promising strategy for managing various diseases.
Abstract Background Colorectal cancer (CRC) is a type of cancer that affects the colon or rectum and occurs in individuals over the age of 50, although it can affect people of all ages. Quercetin is a flavonoid, which is a type of plant pigment with antioxidant and anti-inflammatory properties. Some studies have explored the potential of quercetin as an adjuvant therapy to enhance the effectiveness of chemotherapy or radiation therapy. Methodology In the proposed work, the nano-biomaterials of solid lipids such as stearic acid (SA) and tripalmitin (TpN) as well as the surfactants tween 80 and span 80 were used to prepare novel quercetin (QuR)-loaded-solid lipid nanoparticles (QuR-SLNs) for medical applications in colorectal cancer (CRC). The resulting bio-nano SLNs’ mean entrapment efficiency (EE) and particle size (PS) were optimized by Box–Behnken design (BBD) approach based on the response-like surface methodology (RSM). The variables include lipid ratio ( X 1 ), surfactant ratio ( X 2 ), QuR-to-lipid ratio ( X 3 ), the sonication time ( X 4 ), and the homogenization time ( X 5 ). Requirements on the maximum EE (%) and minimum PS (nm) were optimized for the preparation of QuR-SLN. Differential scanning calorimetry (DSC), X-ray diffraction (XRD) analysis, and scanning electron microscopy (SEM) were then used to analyze the optimized SLN and to find the crystalline state of QuR with lipid relationship. In addition, on the Caco-2 cells, at IC 50 (49 µM/mL), in vitro cytotoxicity was attained. Results The optimized QuR-SLN had practically spherical shapes, with % EE and a PS of 97.8 ± 1.16% and 132.16 ± 4.1 nm, respectively. In aqueous media, the degree of lipid crystallinity and the lipid modification was investigated, and the QuR incorporation and release patterns showed high correlations with both. The results showed that over 41.12 ± 1.6% of the bio-nano QuR-SLNs was released gradually over the course of 48 h, demonstrating effective QuR delayed release. Results on apoptotic observations indicate that apoptosis accounts for the majority of cell death, while necrosis, a type of cell death, constitutes a very minor portion. In conclusion, the prepared bio-nano QuR-SLNs might improve cytotoxicity and can act as an ideal carrier for the delivery of QuR and this preparation is used in the treatment of CRC.
Disease-modifying anti-rheumatic drugs (DMARDs) is a class of anti-rheumatic medicines that are frequently prescribed to patients suffering from rheumatoid arthritis (RA). Methotrexate, sulfasalazine, hydroxychloroquine, and azathioprine are examples of non-biologic DMARDs that are being used for alleviating pain and preventing disease progression. Biologic DMARDs (bDMARDs) like infliximab, rituximab, etanercept, adalimumab, tocilizumab, certolizumab pegol, and abatacept have greater effectiveness with fewer adverse effects in comparison to non-biologic DMARDs. This review article delineates the classification of DMARDs and their characteristic attributes. The poor aqueous solubility or permeability causes the limited oral bioavailability of synthetic DMARDs, while the high molecular weights along with the bulky structures of bDMARDs have posed few obstacles in their drug delivery and need to be addressed through the development of nanoformulations like cubosomes, nanospheres, nanoemulsions, solid lipid nanoparticles, nanomicelles, liposome, niosomes, and nanostructured lipid carrier. The main focus of this review article is to highlight the potential role of nanotechnology in the drug delivery of DMARDs for increasing solubility, dissolution, and bioavailability for the improved management of RA. This article also focusses on the different aspects of nanoparticles like their applications in biologics, biocompatibility, body clearance, scalability, drug loading, and stability issues.
Frontiers in Cellular and Infection Microbiology · مجلد 13 · 1322778-1322778
The advent of nanotechnology has been instrumental in the development of new drugs with novel targets. Recently, metallic nanoparticles have emerged as potential candidates to combat the threat of drug-resistant infections. Diabetic foot ulcers (DFUs) are one of the dreadful complications of diabetes mellitus due to the colonization of numerous drug-resistant pathogenic microbes leading to biofilm formation. Biofilms are difficult to treat due to limited penetration and non-specificity of drugs. Therefore, in the current investigation, SnO2 nanoparticles were biosynthesized using Artemisia vulgaris (AvTO-NPs) as a stabilizing agent and were characterized using ultraviolet–visible (UV–vis) spectroscopy, Fourier transform infrared spectroscopy (FT-IR), X-ray diffraction (XRD), scanning electron microscopy (SEM), and energy-dispersive X-ray spectroscopy (EDX). Furthermore, the efficacy of AvTO-NPs against biofilms and virulence factors of drug-resistant Candida albicans strains isolated from DFUs was assessed. AvTO-NPs displayed minimum inhibitory concentrations (MICs) ranging from 1 mg/mL to 2 mg/mL against four strains of C. albicans. AvTO-NPs significantly inhibited biofilm formation by 54.8%–87%, germ tube formation by 72%–90%, cell surface hydrophobicity by 68.2%–82.8%, and exopolysaccharide (EPS) production by 69%–86.3% in the test strains at respective 1/2xMIC. Biosynthesized NPs were effective in disrupting established mature biofilms of test strains significantly. Elevated levels of reactive oxygen species (ROS) generation in the AvTO-NPs-treated C. albicans could be the possible cause of cell death leading to biofilm inhibition. The useful insights of the present study could be exploited in the current line of treatment to mitigate the threat of biofilm-related persistent DFUs and expedite wound healing.
The application of nanotechnology to cancer research has resulted in substantial advancements. In this study, gold nanoparticles (AuNPs) synthesised utilising environmentally friendly methods are evaluated for their potential as multipurpose theranostic agents in cancer treatment. These eco-friendly AuNPs are attractive candidates for theranostic applications that combine diagnosis and therapy due to their specific physicochemical features. Green nanotechnology practises that use only sustainable, biocompatible materials promote biocompatibility in biomedical applications while reducing environmental impact. Imaging techniques such as optical coherence tomography, surface-enhanced Raman scattering, and photoacoustic imaging can benefit from AuNPs in part due to their optical properties. Their surface plasmon resonance (SPR) can be adjusted, improving imaging contrast and allowing for tailored administration of therapeutic payloads. The localised SPR effect of AuNPs also increases the efficacy of photothermal treatment (PTT) by converting near-infrared light into localised heat and inducing hyperthermia in cancer cells. Because of the localised heating, the cancer may be ablated precisely and with minimal collateral damage. AuNPs can be observed and assessed in real time as part of a multimodal imaging platform, in addition to being used as diagnostic and therapeutic tools. The primary focus of this research is on recent breakthroughs in the production of AuNPs using green nanotechnology techniques, particularly those that have occurred beyond 2020, and their potential applications in cancer theranostics. We are investigating various techniques for functionalizing AuNPs with specific ligands, medications, and imaging agents in order to improve therapeutic efficacy. We also go over the regulatory considerations and toxicity assessments that must be considered when bringing these nanomaterials into clinical use, as well as the potential that exist.
Journal of Saudi Chemical Society · مجلد 27 (5) · 101716-101716
The wastewater released from industries contains many harmful materials like organic dyes and toxic metal ions which badly affect our environment. Nanotechnology is one of the unique approaches to reducing these chemicals. In current research work monometallic ZnO and Co-ZnO bimetallic NPs were synthesized from Brassica rapa leave’s extract and then these were employed for the elimination of methylene blue (MB) and metal ions of Cu (II). Characterization was done by several analytical techniques such as EDX, FTIR, UV-Visible spectroscopy, SEM and XRD. The average diameter of ZnO and Co-ZnO BMNPs was found to be 32.94 nm and 13.82 nm assessed by XRD analysis. The SEM investigation revealed that the produced NPs had a spherical shape. Three distinct methods have opted to determine the antioxidant potential of synthesized NPs. Different factors like pH, contact time, NPs conc., dye conc. and temperature were studied for the elimination of dye while for the eradication of Cu (II) ions; pH, contact time, NPs conc. and adsorbate doses were studied. Adsorption isotherm and kinetic studies were employed for MB and Cu (II) ions elimination while thermodynamic studies were also done for the elimination of MB.
green synthesiszinc oxide nanoparticlescobalt-doped zinc oxidemethylene blue removal
Rheumatoid arthritis (RA) is a long-term autoimmune disease. As nanotechnology has advanced, a growing number of nanodrugs have been used in the treatment of RA due to their unique physical and chemical properties. The purpose of this study was to assess the therapeutic potential of a novel zeolite/vitamin B12 nanocomposite (Nano ZT/Vit B12) formulation in complete Freund's adjuvant (CFA)-induced arthritis. The newly synthesized Nano ZT/Vit B12 was fully characterized using various techniques such as XRD, FT-IR, BET analysis, HERTEM, SEM, practical size, zeta potential, XRF, and EDX. The anti-arthritic, anti-inflammatory, and antioxidant activities as well as the immunomodulation effect of Nano ZT/Vit B12 on the CFA rat model of arthritis were examined. Histopathologic ankle joint injuries caused by CFA intrapedal injection included synovium hyperplasia, inflammatory cell infiltration, and extensive cartilage deterioration. The arthritic rats' Nano ZT/Vit B12 supplementation significantly improved these effects. Furthermore, in arthritic rats, Nano ZT/Vit B12 significantly reduced serum levels of RF and CRP, as well as the levels of IL-1β, TNF-α, IL-17, and ADAMTS-5, while increasing IL-4 and TIMP-3 levels. Nano-ZT/Vit B12 significantly declined the LPO level and increased antioxidant activities, such as GSH content and GST activity, in the arthritic rats. In arthritic rats, Nano ZT/Vit B12 also reduced TGF-β mRNA gene expression and MMP-13 protein levels. Collectively, Nano ZT/Vit B12 seems to have anti-arthritic, anti-inflammatory, and antioxidant properties, making it a promising option for RA in the future.
It is worthwhile to note that using natural products today has shown to be an effective strategy for attaining the therapeutic goal with the highest impact and the fewest drawbacks. In Saudi Arabia, date palm (Phoenix dactylifera) is considered the principal fruit owing to its abundance and incredible nutritional benefits in fighting various diseases. The main objective of the study is to exploit the natural products as well as the nanotechnology approach to obtain great benefits in managing disorders. The present investigation focused on using the powder form of date palm extract (DPE) of Khalas cultivar and incorporates it into a nanolipid formulation such as a nanostructured lipid carrier (NLC) prepared with palm oil. Using the quality by design (QbD) methodology, the most optimized formula was chosen based on the number of assigned parameters. For more appropriate topical application, the optimized DP-NLC was combined with a pre-formulated hydrogel base forming the DP-NLC-hydrogel. The developed DP-NLC-hydrogel was evaluated for various physical properties including pH, viscosity, spreadability, and extrudability. Additionally, the in vitro release of the formulation as well as its stability upon storage under two different conditions of room temperature and refrigerator were investigated. Eventually, different bacterial strains were utilized to test the antibacterial efficacy of the developed formulation. The optimized DP-NLC showed proper particle size (266.9 nm) and in vitro release 77.9%. The prepared DP-NLC-hydrogel showed acceptable physical properties for topical formulation, mainly, pH 6.05, viscosity 9410 cP, spreadability 57.6 mm, extrudability 84.5 (g/cm2), and in vitro release 42.4%. Following three months storage under two distinct conditions, the formula exhibited good stability. Finally, the antibacterial activity of the developed DP-NLC-hydrogel was evaluated and proved to be efficient against various bacterial strains.
date palmnanostructured lipid carrierspalm oilantibacterial activity